Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if an investigational drug, NGX-4010
(high-concentration capsaicin patch), is safe, tolerable and effective in treating painful
HIV-associated neuropathy.